Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Conditioning Regimens and Outcomes after Allogeneic Hematopoietic Cell Transplant for Hyperinflammatory Inborn Errors of Immunity

Rebecca A. Marsh, Soyoung Kim, Kyle Hebert, Christopher C. Dvorak, MD, Victor Aquino, MD, K. Scott Scott Baker, MD MS, Deepak Chellapandian, MD, Blachy Davila, MD, Christine Duncan, MD, Michael J. Eckrich, MD MPH, George E. Georges, MD, Timothy S. Olson, MD PhD, Michael A Pulsipher, MD, Shalini Shenoy, MD, Elizabeth Stenger, MD, Mark Vander Lugt, MD, Lolie C. Yu, MD, Andrew Gennery, MD, Mary Eapen, MBBS, MS

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-139930

Published: 2020

Journal Articles

In Utero Stem Cell Transplantation in Patients with Alpha Thalassemia Major: Interim Results of a Phase 1 Clinical Trial

Tippi C. MacKenzie, MD, Michela Frascoli, Renan Sper, Billie Rachael Lianoglou, MS, Juan Gonzalez Velez, Christopher C. Dvorak, MD, Sandhya Kharbanda, MD, Elliott Vichinsky, MD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-142698

Published: 2020

Journal Articles

First Report of Non-Genotoxic Conditioning with JSP191 (anti-CD117) and Hematopoietic Stem Cell Transplantation in a Newly Diagnosed Patient with Severe Combined Immune Deficiency

Blood (2020) 136 (Supplement 1): 10.

https://doi.org/10.1182/blood-2020-137762

Published: 2020

Journal Articles

Reduced Toxicity Conditioning for Non-Malignant Hematopoietic Cell Transplants

Cristina F Contreras, BS, Janel R Long-Boyle, PharmD, PhD, Kristin A. Shimano, MD, Jasmeen Dara, MD, James N Huang, MD, Sandhya Kharbanda, MD, Alexis Melton, MD PhD, Christine Higham, MD, Morton J Cowan, MD, Christopher C. Dvorak, MD

Blood (2019) 134 (Supplement_1): 4481.

https://doi.org/10.1182/blood-2019-127218

Published: 2019

Journal Articles

Role of Disease Mechanism in Hematopoietic Cell Transplantation Outcomes for Hemophagocytic Lymphohistiocytosis

Aleksandra S. Dain, MD, Michelle L. Hermiston, MD PhD, Kristin A. Shimano, MD, Sandhya Kharbanda, MD, Alexis Melton, MD PhD, Jasmeen Dara, MD, James N Huang, MD, Christopher C. Dvorak, MD

Blood (2019) 134 (Supplement_1): 3343.

https://doi.org/10.1182/blood-2019-127397

Published: 2019

Journal Articles

Incidence and Cost of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with and without Multi-Organ Dysfunction: Analysis of the Premier Healthcare Database

Christopher C. Dvorak, MD, Zhun Cao, PhD, Kwanza Price, MPH, JeanPierre Coaquira, Craig Lipkin, Scott Robinson, Partow Kebriaei, MD

Blood (2019) 134 (Supplement_1): 4706.

https://doi.org/10.1182/blood-2019-123499

Published: 2019

Journal Articles

Next Generation Sequence Minimal Residual Disease (NGS-MRD) Predicts Outstanding Event Free Survival (EFS) Regardless of Hematopoietic Cell Transplantation (HCT) Preparative Approach or Graft Alpha/Beta Depletion in Children with Acute Lymphoblastic Leukemia (ALL)

Hisham Abdel-Azim, Christopher C. Dvorak, MD, Nancy Bunin, MD, Mark C. Walters, MD, Julie-An Talano, MD, Eric Jon Anderson, MD, Jemily Malvar, MS, May Al Jassani, Sonali Chaudhury, MBBS,MD, Mitchell S Cairo, MD, Carrie Kitko, MD, Allison P. Jacob, Dimitri S. Monos, PhD, Leung Wing, MD PhD, Michael A. Pulsipher, MD

Blood (2019) 134 (Supplement_1): 4624.

https://doi.org/10.1182/blood-2019-131706

Published: 2019

Journal Articles

Non-Genotoxic Anti-CD117 Antibody Conditioning Results in Successful Hematopoietic Stem Cell Engraftment in Patients with Severe Combined Immunodeficiency

Rajni Agarwal, MD, Christopher C. Dvorak, MD, Hye-Sook Kwon, PhD, Janel R Long-Boyle, PharmD, PhD, Susan S Prohaska, PhD MS, Janice W Brown, MD, Anne Le, Alyssa Guttman-Klein, Irving L Weissman, MD, Morton J Cowan, MD, Aaron C. Logan, MD PhD, Kenneth I. Weinberg, MD, Robertson Parkman, MD, Maria-Grazia Roncarolo, MD, Judith A Shizuru, MD PhD

Blood (2019) 134 (Supplement_1): 800.

https://doi.org/10.1182/blood-2019-126239

Published: 2019

Journal Articles

Related and Unrelated Donor Transplantation for β Thalassemia Major: Results of an International Survey

Blood (2018) 132 (Supplement 1): 308.

https://doi.org/10.1182/blood-2018-99-111152

Published: 2018

Journal Articles

Poor Outcome of Domino Hematopoietic Stem Cell Transplantation in Humans - an International Case Series

Mirjam Belderbos, MD PhD, Andrew Gennery, MD, Christopher C. Dvorak, MD, Henric-Jan Blok, Juliana Silva, MD, Paul Veys, MD PhD, Benedicte Neven, MD, Rebecca Buckley, MD, Theresa Cole, MD, Morton Jerome Cowan, MD, W. Scott Goebel, MD PhD, Manfred Hoenig, MD, Caroline Kuo, MD, Richard Stiehm, MD PhD, Robert Wynn, MD, Marc Bierings, MD PhD

Blood (2017) 130 (Supplement 1): 2032.

https://doi.org/10.1182/blood.V130.Suppl_1.2032.2032

Published: 2017

Journal Articles

Comparison of Outcomes for Myeloablative Conditioning Regimens Combining Busulfan with Either Cyclophosphamide or Fludarabine in Children

Andrew C. Harris, MD, Jaap Jan Boelens, MDPhD, Kwang Woo Ahn, PhD, Mingwei Fei, MS, Allistair Abraham, MD, Andrew Artz, MD, Christopher C. Dvorak, MD, Haydar Frangoul, MD, Cesar O Freytes, MD, Robert Peter Gale, MD PhD, Sanghee Hong, MD, Hillard M. Lazarus, MD, Shin Mineishi, MD, Taiga Nishihori, MD, Tracey O'Brien, MD, Kirsten M. Williams, MD, Marcelo C. Pasquini, MD, John E Levine, MD MS

Blood (2016) 128 (22): 664.

https://doi.org/10.1182/blood.V128.22.664.664

Published: 2016

Journal Articles

Azacitidine Administration Following Hematopoietic Stem Cell Transplantation Is Safe and Feasible in Children with Acute Leukemia

Justin T. Wahlstrom, MD, Biljana N. Horn, MD, Carol Fraser-Browne, Rebecca Hoeweler, Ying Lu, PhD, Alexis Melton, MD PhD, Jennifer Willert, MD, Christopher C. Dvorak, MD

Blood (2016) 128 (22): 4805.

https://doi.org/10.1182/blood.V128.22.4805.4805

Published: 2016

Journal Articles

Daratumumab Is Effective in the Treatment of Refractory Post-Transplant Autoimmune Hemolytic Anemia: A Pediatric Case Report

Vanessa P. Tolbert, MD, Robert Goldsby, MD, James Huang, MD, Kristin Shimano, MD, Alexis Melton, MD PhD, Jennifer Willert, MD, Biljana N. Horn, MD, Christopher C. Dvorak, MD, Justin T. Wahlstrom, MD

Blood (2016) 128 (22): 4819.

https://doi.org/10.1182/blood.V128.22.4819.4819

Published: 2016

Journal Articles

Hospital Cost Associated with Veno-Occlusive Disease (VOD) in Patients with Hematopoietic Stem Cell Transplant (HSCT)

Christopher C. Dvorak, MD, Bijan Nejadnik, MD, Zhun Cao, PhD, Craig Lipkin, MS, Scott B. Robinson, MA, MPH, Kathleen F. Villa, MS

Blood (2015) 126 (23): 4452.

https://doi.org/10.1182/blood.V126.23.4452.4452

Published: 2015

Journal Articles

Incidence of Hepatic Veno-Occlusive Disease (VOD) in Premier Healthcare Database

Christopher C. Dvorak, MD, Bijan Nejadnik, MD, Zhun Cao, PhD, Craig Lipkin, MS, Scott B. Robinson, MA, MPH, Kathleen F. Villa, MS

Blood (2015) 126 (23): 3280.

https://doi.org/10.1182/blood.V126.23.3280.3280

Published: 2015

Journal Articles

Risk Factors for Graft Failure with Busulfan/Fludarabine-Based Conditioning in Children Undergoing Allogeneic Hematopoietic Cell Transplantation for Nonmalignant Disorders

Benjamin Huang, MD, Christopher C. Dvorak, MD, Justin Wahlstrom, MD, Jimmy Hwang, PhD, Janel R Long-Boyle, PharmD, PhD, Morton Jerome Cowan, MD, Biljana N. Horn, MD

Blood (2014) 124 (21): 1155.

https://doi.org/10.1182/blood.V124.21.1155.1155

Published: 2014

Journal Articles

Risk Factors For Relapse In Children Undergoing Preemptive Immunomodulatory Therapy After Allogeneic Hematopoietic Stem Cell (HSCT) For Acute Leukemia

Marie Ouachee-Chardin, MD, Christopher C. Dvorak, MD, Justin Wahlstrom, MD, Morton Jerome Cowan, MD, Janelle Facchino, PNP, Biljana N. Horn, MD

Blood (2013) 122 (21): 2082.

https://doi.org/10.1182/blood.V122.21.2082.2082

Published: 2013

Journal Articles

An Interim Evaluation of Systemic F-Ara-a Exposure in Pediatric Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients Using An Optimal Sampling Design

Janel R Long-Boyle, PharmD, PhD, Shirley Yan, BS, Christopher C. Dvorak, MD, Biljana N. Horn, MD, Morton Jerome Cowan, MD, Liusheng Huang, PhD, Nancy Sambol, PharmD, Lisa Musick, PharmD, Francesca Aweeka, PharmD

Blood (2011) 118 (21): 1962.

https://doi.org/10.1182/blood.V118.21.1962.1962

Published: 2011

Journal Articles

Delayed Platelet Engraftment and Early Increased Creatinine after Stem Cell Transplant Predicts Sustained Remission in Pediatric Leukemia.

Meera Sridhar, MS, Christopher C. Dvorak, MD, Rajni Agarwal, MD, Joshua D. Schiffman, MD

Blood (2008) 112 (11): 2159.

https://doi.org/10.1182/blood.V112.11.2159.2159

Published: 2008

NARROW

Conditioning Regimens and Outcomes after Allogeneic Hematopoietic Cell Transplant for Hyperinflammatory Inborn Errors of Immunity

In Utero Stem Cell Transplantation in Patients with Alpha Thalassemia Major: Interim Results of a Phase 1 Clinical Trial

First Report of Non-Genotoxic Conditioning with JSP191 (anti-CD117) and Hematopoietic Stem Cell Transplantation in a Newly Diagnosed Patient with Severe Combined Immune Deficiency

Reduced Toxicity Conditioning for Non-Malignant Hematopoietic Cell Transplants

Role of Disease Mechanism in Hematopoietic Cell Transplantation Outcomes for Hemophagocytic Lymphohistiocytosis

Incidence and Cost of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with and without Multi-Organ Dysfunction: Analysis of the Premier Healthcare Database

Next Generation Sequence Minimal Residual Disease (NGS-MRD) Predicts Outstanding Event Free Survival (EFS) Regardless of Hematopoietic Cell Transplantation (HCT) Preparative Approach or Graft Alpha/Beta Depletion in Children with Acute Lymphoblastic Leukemia (ALL)

Non-Genotoxic Anti-CD117 Antibody Conditioning Results in Successful Hematopoietic Stem Cell Engraftment in Patients with Severe Combined Immunodeficiency

Related and Unrelated Donor Transplantation for β Thalassemia Major: Results of an International Survey

Poor Outcome of Domino Hematopoietic Stem Cell Transplantation in Humans - an International Case Series

Comparison of Outcomes for Myeloablative Conditioning Regimens Combining Busulfan with Either Cyclophosphamide or Fludarabine in Children

Azacitidine Administration Following Hematopoietic Stem Cell Transplantation Is Safe and Feasible in Children with Acute Leukemia

Daratumumab Is Effective in the Treatment of Refractory Post-Transplant Autoimmune Hemolytic Anemia: A Pediatric Case Report

Hospital Cost Associated with Veno-Occlusive Disease (VOD) in Patients with Hematopoietic Stem Cell Transplant (HSCT)

Incidence of Hepatic Veno-Occlusive Disease (VOD) in Premier Healthcare Database

Risk Factors for Graft Failure with Busulfan/Fludarabine-Based Conditioning in Children Undergoing Allogeneic Hematopoietic Cell Transplantation for Nonmalignant Disorders

Risk Factors For Relapse In Children Undergoing Preemptive Immunomodulatory Therapy After Allogeneic Hematopoietic Stem Cell (HSCT) For Acute Leukemia

An Interim Evaluation of Systemic F-Ara-a Exposure in Pediatric Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients Using An Optimal Sampling Design

Delayed Platelet Engraftment and Early Increased Creatinine after Stem Cell Transplant Predicts Sustained Remission in Pediatric Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only